Market Research Future

Hyperglycemia Treatment Market Is Expected to Grow at a CAGR of 9.8 % Forecast Till 2023


Pune, India -- (SBWIRE) -- 10/27/2017 -- Executive Summary

Market Research Future published new report, titled "Hyperglycemia Treatment Market -Research Report: Global Forecast till 2023".

Market Synopsis of Global Hyperglycemia Treatment Market:

Market Scenario:

Hyperglycemia is an excess of glucose in the bloodstream, and is often associated with diabetes mellitus. It occurs when the body does not have enough insulin to control the sugar level or unable to produce the insulin. Furthermore, hyperglycemia if remains untreated may cause serious complications such as nerve damage or neuropathy, kidney damage, kidney failure, cardiovascular disease, eye disease, and skin problems such as bacterial and fungal infections. The major signs of hyperglycemia are polydipsia (a great thirst), polyuria (a need to urinate often), and a dry mouth.

Increasing prevalence of diabetes, and growing investment in biotechnology and pharmaceutical industries, and rising need for the better treatment methods drive the growth of the market.

According to the WHO, the global prevalence of diabetes among adults over 18 years of age has risen from 4.7% in 1980 to 8.5% in 2014. Where as in 2015, 1.6 million deaths were caused due to diabetes. Another, 2.2 million deaths were attributed to high blood glucose level in 2012.

According to the WHO estimates, neurological disorders are responsible for 4.5%-11% of all illnesses including low or high income economies across the globe. This is higher than the number of respiratory ailments, gastrointestinal disorders, or cancers, and the burden is expected to increase further over the coming years.

Moreover, increasing awareness about diabetes care and management, and advancing technology in medical devices are adding fuel to the growth of the market. Furthermore, increasing prevalence of obesity and consumption of unhealthy diet also drive the market growth.

However, availability of expensive treatment and poor reimbursement policy are some of the factors, which may slow the market growth during the forecast period.

The global hyperglycemia treatment market is expected to grow at a CAGR of 9.8 % during the forecast period 2017-2023.

Key Players:

Some of key the players in the market are Novo Nordisk A/S, Merck & Company Inc., Medtronic, Johnson & Johnson Services, Inc. , Teva Pharmaceuticals Ltd., Eli Lilly and Company, Sanofi S.A., Home Diagnostics, Bayer AG, Bristol-Myers Squibb., and Abbott.


Market Segments:

The global hyperglycemia treatment market is segmented on the basis of treatment, mode of administration, and end user.

On the basis of treatment, it is segmented into fluid replacement, electrolyte replacement, insulin therapy, and drugs. The drugs segment is further segmented into sulfonylureas, biguanides, thiazolidinedione's, and others.

On the basis of mode of administration, it is segmented into topical, oral, and others.

On the basis of end user, the market is segmented into hospitals & clinics, retail pharmacy, and others

Intended Audience:

Pharmaceutical Companies
Medical Devices Companies
Research and Development (R&D) Companies
Government Research Institute
Academic Institutes and Universities
Regional Analysis:

The Americas dominates the Global Hyperglycemia Treatment Market owing to well-developed technology, increasing patient with diabetes, increasing prevalence of neurological disorders, increasing patient population of kidney failure caused by severe hyperglycemia, high healthcare spending, and increasing government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region.

Europe holds the second position in the global hyperglycemia treatment market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. For instance, countries like Germany and France are increasing investment in the healthcare domain.

Asia Pacific is the fastest growing hyperglycemia treatment market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods in countries like India and South Korea is likely to emerge as the fastest growing market across the globe. Furthermore, increasing demand for quality devices in the healthcare projected to lead to the use of advanced equipment, which, in turn, will increase the market growth of the hyperglycemia treatment in the region.

On the other hand, the Middle East & Africa holds the least share of the market due to limited availability of medical facilities, less availability of funds, and poor political conditions in Africa.

Table of Contents

1 Report Prologue

2 Market Introduction

3 Research Methodology

4 Market Dynamics

5 Market Factor Analysis

6 Global Hyperglycemia Treatment Market, By Treatments

7 Global Hyperglycemia Treatment Market, By Mode of Administration

8 Global Hyperglycemia Treatment Market, By End User

9 Global Hyperglycemia Treatment Market, By Region

10 Company Landscape

11 Company Profiles

12 MRFR Conclusion

13 Appendix

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.